In de context moet je zoeken: Analyse van melanoma door middel van nieuwe generatie pathologische ontleedkunde
Year: 2024
Type: dissertation
Study design: Study Protocol
Abstract: Immune-checkpoint inhibitors (ICI) are new treatments for cancer. The purpose of this type of treatment is to activate the immune system of the patient in order to elicit an anti-tumor immune response. Numerous clinical trials proved that ICI are active in different cancer types and in some metastatic malignancies they are even standard of care. ICI are generally well tolerated and can induce long lasting tumor control and possibly even cure in some patients. The disadvantage is that only a fraction of the patients responds well. The mechanisms responsible for this are largely unknown. Within this project we would like to study these mechanisms. We would like to explore not only the immune response network in tissues of patients with metastatic malignant melanoma receiving ICI ('the tumoral micro-environment), but also focus on exposing the different melanoma phenotypes to gain insights into intra- and inter-patient heterogeneity. We will analyze cellular markers on a single cell level by using multiplexed protein analysis and investigate whether these markers differ in patients responding from those not responding. Also, by prospectively collecting serial biopsies from the same patients, we will investigate dynamic sequential biomarker changes during immunotherapy in both the tumor and the tumor niche.
Source: Lirias
Author: Van Herck, Yannick
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7055757124
